Cargando…

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization

OBJECTIVE: To analyze the fluorescent in situ hybridization (FISH) data and the association with clinical characteristics, therapy response, and survival time in patients with multiple myeloma. METHOD: We performed a retrospective review of patients with multiple myeloma from November 2010 to April...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ying, Chen, Wenming, Chen, Shilun, Huang, Zhongxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780433/ https://www.ncbi.nlm.nih.gov/pubmed/27042105 http://dx.doi.org/10.2147/OTT.S95818

Ejemplares similares

Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma
por: Perumal, G, et al.
Publicado: (2014)

Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification
por: Abdel-Qader, Hadeel Yaseen, et al.
Publicado: (2022)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
por: Crabtree, Matthew, et al.
Publicado: (2022)

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
por: Merz, Maximilian, et al.
Publicado: (2017)

Analysis of clinical features, treatment response, and prognosis among 61 elderly newly diagnosed multiple myeloma patients: a single-center report
por: An, Na, et al.
Publicado: (2015)

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
por: Abdallah, Nadine, et al.
Publicado: (2020)

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
por: Govindasamy, Perumal, et al.
Publicado: (2019)

Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients
por: Hamdaoui, Hasna, et al.
Publicado: (2023)

Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma
por: Smadbeck, James, et al.
Publicado: (2019)

Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia
por: Shetty, Dhanlaxmi, et al.
Publicado: (2021)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma
por: Wei, Yujun, et al.
Publicado: (2022)

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
por: Greenberg, A J, et al.
Publicado: (2015)

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
por: Greenberg, A J, et al.
Publicado: (2015)

Molecular Cytogenetic Characterization of Drug‐resistant Leukemia Cell Lines by Comparative Genomic Hybridization and Fluorescence in situ Hybridization
por: Shimizu, Hajime, et al.
Publicado: (2002)

Diagnostic Utility of Multiprobe Fluorescence in situ Hybridization Assay for Detecting Cytogenetic Aberrations in Acute Leukemia
por: Kim, Bo-Ram, et al.
Publicado: (2014)

Cytogenetic Abnormalities in Multiple Myeloma: Incidence, Prognostic Significance, and Geographic Heterogeneity in Indian and Western Populations
por: Kadam Amare, Pratibha, et al.
Publicado: (2023)

Interphase cytogenetics of non-Hodgkin's lymphoma using non-fluorescent in situ hybridization in paraffin embedded tissue.
por: Choi, Y. J., et al.
Publicado: (1996)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
por: Moutmir, Yasmine, et al.
Publicado: (2023)

Comparative Cytogenetics Analysis of Chlamys farreri, Patinopecten yessoensis, and Argopecten irradians with C(0)t-1 DNA by Fluorescence In Situ Hybridization
por: Hu, Li-Ping, et al.
Publicado: (2011)

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
por: LIU, NIAN, et al.
Publicado: (2015)

Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma
por: Zheng, Dong, et al.
Publicado: (2022)

Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization
por: Okamoto, I, et al.
Publicado: (1999)

Specific cytogenetic labeling of bovine spermatozoa bearing X or Y chromosomes using fluorescent in situ hybridization (FISH)
por: Piumi, François, et al.
Publicado: (2001)

Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?
por: Kim, Dong Uk
Publicado: (2020)

Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma
por: Ma, Edmond S. K., et al.
Publicado: (2016)

Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells
por: Kishimoto, Renata Kiyomi, et al.
Publicado: (2016)

Comment on: “Validation of interphase fluorescence in situ hybridization (iFISH) of CD138 positive cells in multiple myeloma”()
por: Zalcberg Renault, Ilana
Publicado: (2016)

Pros and Cons for Fluorescent in Situ Hybridization, Karyotyping and Next Generation Sequencing for Diagnosis and Follow-up of Multiple Myeloma
por: Ikbal Atli, E, et al.
Publicado: (2021)

Interpretation of cytogenetic results in multiple myeloma for clinical practice
por: Rajan, A M, et al.
Publicado: (2015)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

Conventional and Molecular Cytogenetic Analyses in Turkish Patients with Multiple Myeloma
por: Durak, Beyhan Aras, et al.
Publicado: (2012)

Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients
por: Hamdaoui, Hasna, et al.
Publicado: (2020)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
por: Ye, Fang, et al.
Publicado: (2021)

AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival
por: Ozga, Michael, et al.
Publicado: (2020)

Progress in the identification of gene mutations involved in multiple myeloma
por: Hu, Ying, et al.
Publicado: (2019)

Interphase Cytogenetics of Lung Tumors Using In Situ Hybridization: Numerical Aberrations
por: Kim, Sun Young, et al.
Publicado: (1994)

Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma
por: Yang, Naery, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5hqvttg3l6ivft86h08siugntf